Altium Capital Management »

Vsee Health shares owned by Altium Capital Management

Quarter-by-quarter ownership of Vsee Health (VSEEW) shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Vsee Health

Tip: Access up to 7 years of quarterly data

All positions including Vsee Health held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vsee Health by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $33k 150k 0.22

More positions owned by Altium Capital Management

Vera Therapeutics Cl A (VERA)
Adma Biologics (ADMA)
Xenon Pharmaceuticals (XENE)
Intra Cellular Therapies (ITCI)
Sarepta Therapeutics (SRPT)
Insmed Com Par $.01 (INSM)
Alimera Sciences Com New
Skye Bioscience Com New (SKYE)
Argenx Se Sponsored Adr (ARGX)
Soleno Therapeutics (SLNO)
Avadel Pharmaceuticals Com Shs (AVDL)
Catalyst Pharmaceutical Partners (CPRX)
Contineum Therapeutics Cl A (CTNM)
Rezolute Com New (RZLT)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for Altium Capital Management

Top funds holding Vsee Health

MMCAP International Inc. SPC
Exos Asset Management
D. E. Shaw & Co
Clear Street
Whitebox Advisors
Alberta Investment Management Corporation
Saba Capital Management
Cowen And Company
Atw Spac Management
Altium Capital Management
Clear Street Derivatives
Quad-Cities Investment Group
CNH Partners
Wolverine Asset Management
Rivernorth Capital Management

View all funds holding Vsee Health